{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T08:10:17Z","timestamp":1785658217212,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bioactmat.2022.02.019","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T15:32:21Z","timestamp":1645889541000},"page":"469-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement"],"prefix":"10.1016","volume":"15","author":[{"given":"Siqing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2870-6059","authenticated-orcid":false,"given":"Quankui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bioactmat.2022.02.019_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(17)30544-5","volume":"390","author":"Liu","year":"2017","journal-title":"Cataracts. Lancet"},{"issue":"2","key":"10.1016\/j.bioactmat.2022.02.019_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/opep.11.2.67.28158","article-title":"Global update of available data on visual impairment: a compilation of population-based prevalence studies","volume":"11","author":"Pascolini","year":"2002","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biomaterials.2016.02.038","article-title":"A novel capsular tension ring as local sustained-release carrier for preventing posterior capsule opacification","volume":"89","author":"Lei","year":"2016","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.bioactmat.2022.02.019_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaapos.2016.06.011","article-title":"Revisiting secondary capsulotomy for posterior capsule management in pediatric cataract surgery","volume":"20","author":"Elkin","year":"2016","journal-title":"J AAPOS"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.02.019_bib6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jcrs.2019.05.018","article-title":"Posterior capsule opacification rate after phacoemulsification in pediatric cataract: hydrophilic versus hydrophobic intraocular lenses","volume":"45","author":"Sen","year":"2019","journal-title":"J. Cataract Refract. Surg."},{"issue":"11","key":"10.1016\/j.bioactmat.2022.02.019_bib7","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.ajpath.2017.07.018","article-title":"Reduced glutathione level promotes epithelial-mesenchymal transition in lens epithelial cells via a Wnt\/\u03b2-catenin-mediated pathway: relevance for cataract therapy","volume":"187","author":"Wei","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.02.019_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/0885328216638547","article-title":"Surface PEGylation of intraocular lens for PCO prevention: an in vivo evaluation","volume":"31","author":"Xu","year":"2016","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2415-14-116","article-title":"Five-year incidence of Nd:YAG laser capsulotomy and association with in vitro proliferation of lens epithelial cells from individual specimens: a case control study","volume":"14","author":"Sundelin","year":"2014","journal-title":"BMC Ophthalmol."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.02.019_bib10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jcrs.2017.03.046","article-title":"Rate of retinal tear and detachment after neodymium:YAG capsulotomy","volume":"43","author":"Wesolosky","year":"2017","journal-title":"J. Cataract Refract. Surg."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.02.019_bib11","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1167\/iovs.14-14364","article-title":"Prevention of posterior capsule opacification by an intracapsular open capsule device","volume":"55","author":"Alon","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.02.019_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1167\/iovs.18-25930","article-title":"An in vitro human lens capsular bag model adopting a graded culture regime to assess putative impact of IOLs on PCO formation","volume":"60","author":"Eldred","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.02.019_bib13","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1021\/acsabm.0c00331","article-title":"Cellular microenvironment-sensitive drug eluting coating on intraocular lens for enhanced posterior capsular opacification prevention and in vivo biocompatibility","volume":"3","author":"Han","year":"2020","journal-title":"ACS Appl. Bio. Mater."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.131553","article-title":"Cascade catalytic platform modified intraocular lens for high-efficient posterior capsule opacification prevention","volume":"427","author":"Huang","year":"2022","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.132716","article-title":"Photo-responsive intraocular lens with on demand drug release for posterior capsule opacification prevention and improved biosafety","volume":"430","author":"Xia","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"5","key":"10.1016\/j.bioactmat.2022.02.019_bib16","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1021\/bm058010l","article-title":"Surface modification of silicone intraocular implants to inhibit cell proliferation","volume":"6","author":"Yammine","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib17","first-page":"343","article-title":"Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification","volume":"9","author":"Zhang","year":"2022","journal-title":"Bioact Mater"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.02.019_bib18","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1039\/C4TB01934B","article-title":"Engineering and functionalization of biomaterials via surface modification","volume":"3","author":"Wu","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/IJN.S107491","article-title":"Bottom-up fabrication of zwitterionic polymer brushes on intraocular lens for improved biocompatibility","volume":"12","author":"Han","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib20","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.msec.2017.03.029","article-title":"UV-assisted treatment on hydrophobic acrylic IOLs anterior surface with methacryloyloxyethyl phosphorylcholine: reducing inflammation and maintaining low posterior capsular opacification properties","volume":"75","author":"Huang","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.colsurfb.2016.12.028","article-title":"Hydrophilic modification of intraocular lens via surface initiated reversible addition-fragmentation chain transfer polymerization for reduced posterior capsular opacification","volume":"151","author":"Lin","year":"2017","journal-title":"Colloids Surf., B"},{"issue":"4","key":"10.1016\/j.bioactmat.2022.02.019_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/jop.2012.0062","article-title":"Hydrophilic acrylic intraocular lens as a drug delivery system: influence of the presoaking time and comparison to intracameral injection","volume":"29","author":"Lipnitzki","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.02.019_bib23","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3928\/1081597X-20150623-05","article-title":"Prospective randomized intraindividual comparison of posterior capsule opacification after implantation of an IOL with and without heparin surface modification","volume":"31","author":"Krall","year":"2015","journal-title":"J. Refract. Surg."},{"issue":"15","key":"10.1016\/j.bioactmat.2022.02.019_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.actbio.2021.11.018","article-title":"Centrifugally concentric ring-patterned drug-loaded polymeric coating as an intraocular lens surface modification for efficient prevention of posterior capsular opacification","volume":"138","author":"Lu","year":"2022","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.bioactmat.2022.02.019_bib25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1039\/D0TB02530E","article-title":"Enhanced PCO prevention of drug eluting IOLs endocytosis and autophagy effects of a PAMAM dendrimer","volume":"9","author":"Qin","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2020.07.020","article-title":"Dual drug delivery from hydrophobic and hydrophilic intraocular lenses: in-vitro and in-vivo studies","volume":"326","author":"Topete","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib27","first-page":"2181685","article-title":"Research progress of drug prophylaxis for lens capsule opacification after cataract surgery","author":"Zhang","year":"2020","journal-title":"J. Ophthalmol"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib28","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.2147\/IJN.S215802","article-title":"Anti-adhesive and antiproliferative synergistic surface modification of intraocular lens for reduced posterior capsular opacification","volume":"14","author":"Han","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.02.019_bib29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.biotechadv.2017.12.010","article-title":"Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds","volume":"36","author":"Farooqi","year":"2018","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.bioactmat.2022.02.019_bib30","first-page":"75","article-title":"A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy","volume":"1846","author":"Johnsen","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioactmat.2022.02.019_bib31","doi-asserted-by":"crossref","first-page":"13588","DOI":"10.1038\/ncomms13588","article-title":"ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins","volume":"7","author":"Villarroya-Beltri","year":"2016","journal-title":"Nat. Commun."},{"issue":"7659","key":"10.1016\/j.bioactmat.2022.02.019_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bioactmat.2022.02.019_bib33","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.1021\/jacs.8b03584","article-title":"Self-assembly of extracellular vesicle-like metal-organic framework nanoparticles for protection and intracellular delivery of biofunctional proteins","volume":"140","author":"Cheng","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.02.019_bib34","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.biomaterials.2013.11.083","article-title":"A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.02.019_bib35","doi-asserted-by":"crossref","first-page":"2002787","DOI":"10.1002\/advs.202002787","article-title":"Tumor exosomes reprogrammed by low pH are efficient targeting vehicles for smart drug delivery and personalized therapy against their homologous tumor","volume":"8","author":"Gong","year":"2021","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.bioactmat.2022.02.019_bib36","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1021\/acsnano.9b04397","article-title":"Tumor-derived extracellular vesicles breach the intact blood-brain barrier transcytosis","volume":"13","author":"Morad","year":"2019","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.bioactmat.2022.02.019_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081797","article-title":"Feasibility of mechanical extrusion to coat nanoparticles with extracellular vesicle membranes","volume":"9","author":"Van Deun","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioactmat.2022.02.019_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/acs.molpharmaceut.8b00901","article-title":"Exosome as a novel shuttle for delivery of therapeutics across biological barriers","volume":"16","author":"Das","year":"2019","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.bioactmat.2022.02.019_bib39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.02.019_bib40","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/acs.molpharmaceut.5b00364","article-title":"Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery","volume":"12","author":"Lamichhane","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120946","article-title":"Urinary exosomes-based engineered nanovectors for homologously targeted chemo-chemodynamic prostate cancer therapy via abrogating EGFR\/AKT\/NF-kB\/IkB signaling","volume":"275","author":"Pan","year":"2021","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.bioactmat.2022.02.019_bib42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41551-021-00764-3","article-title":"Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells","volume":"5","author":"Tian","year":"2021","journal-title":"Nat. Biomed Eng."},{"issue":"Pt A","key":"10.1016\/j.bioactmat.2022.02.019_bib43","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2016.02.006","article-title":"Extracellular vesicles for drug delivery","volume":"106","author":"Vader","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2022.02.019_bib44","doi-asserted-by":"crossref","first-page":"120784","DOI":"10.1016\/j.biomaterials.2021.120784","article-title":"Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy","volume":"273","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bioactmat.2022.02.019_bib45","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","article-title":"Extracellular vesicle and particle biomarkers define multiple human cancers","volume":"182","author":"Hoshino","year":"2020","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.bioactmat.2022.02.019_bib46","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.7150\/thno.45028","article-title":"Engineering blood exosomes for tumor-targeting efficient gene\/chemo combination therapy","volume":"10","author":"Zhan","year":"2022","journal-title":"Theranostics"},{"issue":"20","key":"10.1016\/j.bioactmat.2022.02.019_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf7207","article-title":"Mesenchymal stromal exosome-functionalized scaffolds induce innate and adaptive immunomodulatory responses toward tissue repair","volume":"7","author":"Su","year":"2021","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.bioactmat.2022.02.019_bib48","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1039\/D0TB02802A","article-title":"Surface modification of intraocular lenses via photodynamic coating for safe and effective PCO prevention","volume":"9","author":"Tang","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.bioactmat.2022.02.019_bib49","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1021\/acsbiomaterials.0c01705","article-title":"Drug-eluting hydrophilic coating modification of intraocular lens via facile dopamine self-polymerization for posterior capsular opacification prevention","volume":"7","author":"Liu","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"7","key":"10.1016\/j.bioactmat.2022.02.019_bib50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.tibtech.2017.03.004","article-title":"Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges","volume":"35","author":"Syn","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"9","key":"10.1016\/j.bioactmat.2022.02.019_bib51","first-page":"2754","article-title":"Exosome-functionalized polyetheretherketone-based implant with immunomodulatory property for enhancing osseointegration","volume":"6","author":"Fan","year":"2021","journal-title":"Bioact Mater"},{"issue":"10","key":"10.1016\/j.bioactmat.2022.02.019_bib52","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41551-021-00705-0","article-title":"Exosome-eluting stents for vascular healing after ischaemic injury","volume":"5","author":"Hu","year":"2021","journal-title":"Nat. Biomed Eng."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X22000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X22000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:04:52Z","timestamp":1762531492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X22000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":52,"alternative-id":["S2452199X22000925"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.019","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2022.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}